Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis
Multiple sclerosis (MS) is a neurodegenerative disease characterized by inflammation and myelin damage. Pro-inflammatory cytokines, oxidative stress, high level of matrix metalloproteinases (MMPs) activity and blood-brain barrier (BBB) damage, immune-mediated destruction of myelin and neuron loss ar...
Saved in:
Main Authors: | Fahimeh Safaeinejad (Author), Soheyl Bahrami (Author), Heinz Redl (Author), Hassan Niknejad (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007) -
Matrix Metalloproteinases in patients with Multiple Sclerosis.
by: Rebeca A. Fernández Carriera, et al.
Published: (2007) -
Bryostatin-1: a promising compound for neurological disorders
by: Zhen Tian, et al.
Published: (2023) -
Matrix Metalloproteinase
Published: (2020) -
Matrix Metalloproteinases
by: S Sahitya, et al.
Published: (2010)